Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Affymax Inc AFFY

Healthcare Biotechnology
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with... see more

Recent & Breaking News (GREY:AFFY)

The Straight Truth, Investing in CLNT, AFFY, TSLA and CLSN

Marketwired June 13, 2013

PennyStocks.com Announces Trade Alerts on: XUII, BIZM, AFFY, and VPCO

Marketwired June 12, 2013

Strategy Behind Our Success, We Get in Early: CLNT, AFFY, TSLA and CLSN

Marketwired June 12, 2013

Secrets to Making Money in CLNT, AFFY, CERP and CLSN

Marketwired June 10, 2013

StockCall Early Morning Insight into AFFY, AMGN, PDLI, QCOR, and BCRX

Accesswire June 7, 2013

Key to Success, How to Profit: CLNT, AFFY, TSLA and CLSN

Marketwired June 7, 2013

Affymax Announces Update on Listing, Senior Leadership and Board Changes

Business Wire June 6, 2013

The Real Story Behind GLW, AFFY and AMAT

Marketwired June 6, 2013

BBRY, ZNGA, AGNC and AFFY added to Nasdaq Active Stock Watch List at EPR

Accesswire June 5, 2013

Perfect Trade Setups, How to Play AFFY, FTR, HOV and PG

Marketwired June 5, 2013

Free Research Reports on AFFY, IGTE, MNRO and VRML Issued by the Bedford Report

Marketwired May 22, 2013

Free Research Reports on AFFY, SRE, SSI and YGE Issued by the Paragon Report

Marketwired May 20, 2013

Special Situation Coming Soon, a Look Inside T, C, AFFY and EMC

Marketwired May 14, 2013

AFFY, GALE, and AVEO added to BioStock Watch List at GSR

Accesswire May 14, 2013

BAC, AIG, TSLA and YNDX added to Active Stock Watch List at EPR

Accesswire May 13, 2013

AFFY, PTIE and DRRX Added to Decliners Watch List at GSR

Accesswire May 10, 2013

Affymax Inc is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Newsfile May 10, 2013

PennyStocks.com Announces Trade Alerts on: AFFY, FNMA, GNIN, and RBCC

Marketwired May 9, 2013

Squawk Box Stocks Reports on: J. C. Penney Company, Inc. (NYSE: JCP), ValueClick, Inc. (NASDAQ: VCLK), Alexza Pharmaceuticals Inc. (NASDAQ: ALXA), Affymax, Inc. (NASDAQ: AFFY)

Marketwired May 9, 2013

AFFY, AMGN, VRTX, and QCOR Early Briefing and Review

Accesswire May 1, 2013